|
⚲
|
| Alnara Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001448422 |
| Sale | 2010-01-25 ($35.0 M Offered, $20.0 M Sold) |
| Fund | |
| Phone | 6173493690 |
| Address | 840 Memorial Drive Cambridge, 02139 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| James Topper | |
| Richard Aldrich | |
| Lee Brettman | |
| Christoph Westphal | |
| Ashley Dombkowski | |
| Robert Gallotto | |
| Alexey Margolin | |
| Robert Tepper |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
KMRB Acquisition Corp.
✚
|
0.0 | |
|
Knell Sandra A
✚
|
0.0 | |
|
Kneppers Chris J
✚
|
0.0 | |
|
SMV Series LLC - Verobotics Seed Series
✚
|
0.0 | |
|
Partners Group Client Access 30, L.P.
✚
|
0.0 | |
|
Partners Group Client Access 32, L.P.
✚
|
0.0 | |
|
Partners Group Client Access 51, L.P.
✚
|
0.0 | |
|
Partners Group Direct Infrastructure 2020 (USD) A,L.P.
✚
|
0.0 | |
|
Partners Group Finance USD IC Ltd
✚
|
0.0 | |
|
KMP Growth Fund II (Ontario), LP
✚
|
0.0 |